Table 3.
Outcomes in patients with and without first pass effect (FPE).
| Variable | FPE(N = 138) | Non-FPE(N = 459) | P-value |
|---|---|---|---|
| Clinical outcomes | |||
| mRS 0–2 at discharge, n/N(%) | 38/100 (38) | 83/338 (25) | 0.0719 |
| mRS 0–2 at 30 days, n/N(%) | 25/54 (46) | 53/165 (32) | 0.0107 |
| mRS 0–2 at 90 days, n/N(%) | 77/122 (63) | 177/398 (44) | 0.0004 |
| NIHSS at discharge, Mean ± SD | 9.1 ± 11.2 | 12 ± 11 | 0.0004 |
| NIHSS at 90 days, Mean ± SD | 14.4 ± 18.5 | 19.2 ± 18.7 | 0.071 |
| Death, n/N (%) | 23/122 (19) | 81/398 (20) | 0.80 |
| Angiographic outcomes | |||
| ENT, n/N (%) | 4/95 (4) | 16/334 (5) | 0.99 |
| EDT in same territory, n/N (%) | 1/104 (1) | 110/371 (30) | <0.0001 |
| sICH, n (%) | 9 (7) | 35 (8) | 0.85 |
EDTL, embolization in distal territory; ENT, embolization in new territory; IQR, interquartile range; NIHSS, National Institutes of Health Stroke Scale; mRS, modified Rankin score; sICH, symptomatic intracerebral hemorrhage. Rows that have mean and median values between groups, p-values correspond to mean, SD values.